Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting

(2010) Shuchita Agarwal et al.   American Journal of Cardiovascular Drugs

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation

(2010) Margaret C. Fang et al.  

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Racial Disparities in Awareness and Treatment of Atrial Fibrillation

(2010) James F. Meschia et al.   STROKE

Anticoagulation for Patients with Atrial Fibrillation in Ambulatory Care Settings

(2009) R. Niska et al.   Journal of the American Board of Family Medicine

Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure

(2009) Jonathan P. Piccini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation

(2008) William R. Lewis et al.   AMERICAN JOURNAL OF CARDIOLOGY

Antithrombotic Therapy in Atrial Fibrillation

(2008) Daniel E. Singer et al.   CHEST

Pharmacology and Management of the Vitamin K Antagonists

(2008) Jack Ansell et al.   CHEST

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation

(2007) Melina Gattellari et al.   STROKE